Analgesia Clinical Trial Experience

Experience in just about every type of pain and major class of analgesics, including every NSAID analgesic on the market today. Leverage our experience as you tackle the most innovative areas of analgesia research.

prcom_Asset 1ARROW

We’re known for analgesia

Laying the foundation for modern pain research

Much of the foundation for modern analgesia research was built here, and we have conducted more studies than any other CRO.

We have performed more than 870 trials across every type of pain, and many of the pain models that are today’s industry standards were invented here. With industry-leading access to patients, sites, and motivated investigators, we get trials running quickly.

Why choose Premier?
  • Unequaled expertise in chronic and acute pain, spanning from disk disease to dental pain
  • Extensive experience in fibromyalgia with 13 studies conducted over the past five years
  • Postoperative bunionectomy model reduces patient recruitment time by up to 40 percent without sacrificing assay sensitivity


The placebo in pain research

Numerous pain studies have failed not because the drugs were ineffective, but because researchers couldn’t statistically separate placebo response from real therapeutic benefit.


Explore the most common neuropathic pain conditions, unique protocol design features required for these varying afflictions, and challenges facing researchers during execution of these clinical studies.

Featured Resources



Picking Neuropathic Pain Trial Sites? Look for Experience – Among Other Things

White Paper

White Paper

Seven Things to Know About Recruiting Patients for Opioid Trials



Managing the Placebo Problem in Chronic Pain Studies

Premier Thought Leadership

Scott Millard

Scott Millard has spent his 25-plus year career focused in analgesia study delivery overseeing the strategy through to execution for analgesia programs. Mr. Millard’s leadership of the analgesia business and study execution expertise is the perfect pairing to provide sponsors with clean data that can be used confidently to support the marketing applications for their drugs in development.

Connect with us

Ready to get started? So are we. Drop us a line to learn more about how we can help.